AegirBio announced that after successfully addressing all non-conformities raised during the unannounced audit of subcontractor in November 2022, sales of the Viraspec Covid-19 test for both home and professional use can now begin again. The ViraSpec Covid 19 antigen test was stopped on 10 November 2022 after an unannounced inspection at one of the Company's key suppliers. The identified non-conformities have now been addressed by the subcontractor wherefor the notified body has lifted the sales ban for the home test.

The test for professional use, which the Company itself sales stopped pending the outcome of the notified body's review, is at the same time made available to the market. ViraSpec Covid 19 test is now available for the home testing market and for professional use.